|
CPOX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.55282511480482E-12 |
| Normal-vs-Stage2 |
4.360000E-04 |
| Normal-vs-Stage3 |
2.30900000000034E-05 |
| Normal-vs-Stage4 |
4.688400E-02 |
| Stage1-vs-Stage2 |
4.017400E-01 |
| Stage1-vs-Stage3 |
3.894200E-02 |
| Stage1-vs-Stage4 |
2.040400E-01 |
| Stage2-vs-Stage3 |
4.706600E-01 |
| Stage2-vs-Stage4 |
2.962400E-01 |
| Stage3-vs-Stage4 |
4.336200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
2.1642000003208E-07 |
| Normal-vs-Asian |
5.008100E-02 |
| Caucasian-vs-AfricanAmerican |
3.338800E-01 |
| Caucasian-vs-Asian |
7.285800E-01 |
| AfricanAmerican-vs-Asian |
4.406600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.36849998000343E-09 |
| Male-vs-Female |
6.980000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.643880E-04 |
| Normal-vs-Extreme_Weight |
1.48669998534245E-09 |
| Normal-vs-Obese |
8.45530001569728E-09 |
| Normal-vs-Extreme_Obese |
5.788200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.545800E-01 |
| Normal_Weight-vs-Obese |
8.676600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.695200E-01 |
| Extreme_Weight-vs-Obese |
1.423380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.989800E-01 |
| Obese-vs-Extreme_Obese |
5.004200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.7533199999975E-05 |
| Normal-vs-Age(41-60Yrs) |
2.93098878501041E-14 |
| Normal-vs-Age(61-80Yrs) |
2.20969909037194E-11 |
| Normal-vs-Age(81-100Yrs) |
3.022300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.424300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.423600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.785300E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.456960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.769680E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.193430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.85807999999454E-05 |
| Normal-VS-KIRP CIMP |
7.554500E-04 |
| Normal-VS-Unclassified PRCC |
1.68739999995005E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.305800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.775900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.572000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.622400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.882000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.736800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.77069999998769E-06 |
| Normal-vs-N1 |
3.56369999999773E-05 |
| Normal-vs-N2 |
3.164600E-01 |
| N0-vs-N1 |
7.119300E-03 |
| N0-vs-N2 |
4.279600E-01 |
| N1-vs-N2 |
6.555200E-01 |
|
|
